VKTX today
$28.05-$0.39 (-1.35%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $22.96
Key levels
Resistance$31.70
Resistance$29.88
Support$27.90
Support$25.36
Latest news & SEC filings
AnalystCanaccord Genuity keeps Buy rating on Viking Therapeutics, lifts target to $118
EarningsViking Therapeutics posts Q3 2026 results and trial updates
All VKTX news →About Viking Therapeutics
Viking Therapeutics is a clinical-stage biopharmaceutical company working on treatments for obesity, liver disease and hormonal conditions. Its main candidate, VK2735, is a dual GLP-1/GIP receptor agonist being tested as both an injection and a pill for weight loss. Other programs include VK2809 for fatty liver disease, VK0214 for a rare inherited neurological disorder, and an early-stage amylin-based obesity treatment.
Based on the company's 10-K filed Feb 11, 2026.
Nasdaq · Healthcare
Viking Therapeutics, Inc. (VKTX)
What Is the Price Target for VKTX?
SEPT Low Target
$65.00
SEPT Mid Target
$91.50
SEPT High Target
$118.00
Analyst Consensus
$91.50
Is VKTX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VKTX.
Start Free Trial →Is VKTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$71.78
12
Moat Score
NONE
1/9
Piotroski Score
21.3
Altman Z-Score
What Is Smart Money Doing with VKTX?
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →VKTX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-215.84%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for VKTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for VKTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:36:14 | $28.12 | 1,062 | $$30K | SELL |
| 14:36:10 | $28.10 | 2,500 | $$70K | SELL |
| 14:35:07 | $28.01 | 1,475 | $$41K | SELL |
| 14:34:40 | $28.03 | 1,000 | $$28K | BUY |
| 14:32:54 | $28.11 | 1,000 | $$28K | BUY |
5 dark pool trades shown · $$198K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for VKTX
PREVIEWSEPT Investing provides real-time options flow tracking for VKTX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $35 | Dec 18 | 36 | $$752 | 1 | SWEEP |
| PUT | $35 | Nov 20 | 8 | $$723 | 1 | SWEEP |
| PUT | $35 | Nov 20 | 8 | $$724 | 1 | SWEEP |
| PUT | $35 | Nov 20 | 8 | $$725 | 1 | SWEEP |
| PUT | $35 | Dec 18 | 36 | $$753 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Viking Therapeutics, Inc. (VKTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →VKTX — frequently asked questions
What is VKTX stock price today?
Viking Therapeutics, Inc. (VKTX) is at $28.05, down 1.35% (-$0.39) at the Nov 12, 2026 close.
Why is VKTX stock moving today?
Latest VKTX news — Oct 30, 2026: Canaccord Genuity keeps Buy rating on Viking Therapeutics, lifts target to $118 · Oct 30, 2026: Viking Therapeutics posts Q3 2026 results and trial updates
What is the VKTX price target?
The average analyst price target for VKTX is $91.50, ranging from $65 to $118, based on 6 analysts. Latest: Canaccord Genuity maintains on Oct 30, 2026.
What do analysts rate VKTX?
Analyst ratings for VKTX: 19 Buy, 2 Hold, 0 Sell — consensus Strong Buy.
Did VKTX beat earnings?
VKTX last reported on Oct 28, 2026: EPS -$1.55 vs -$1.06 expected — a miss of 46.2%.
Does VKTX pay a dividend?
VKTX does not currently pay a dividend.
What are VKTX support and resistance levels?
Support: $27.90, $25.36. Resistance: $29.88, $31.70, $34.95.
What are insiders doing with VKTX?
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
What is the latest news on VKTX?
Oct 30, 2026: Canaccord Genuity keeps Buy rating on Viking Therapeutics, lifts target to $118 · Oct 30, 2026: Viking Therapeutics posts Q3 2026 results and trial updates